PBL Solutions Limited v AFT Pharmaceuticals Limited

Link copied
Case Copied 31 min read
ORDER PROHIBITING PUBLICATION OF UNREDACTED VERSION OF THIS JUDGMENT.

IN THE HIGH COURT OF NEW ZEALAND AUCKLAND REGISTRY

I TE KŌTI MATUA O AOTEAROA TĀMAKI MAKAURAU ROHE

CIV-2020-404-801

[2024] NZHC 1511

BETWEEN

PBL SOLUTIONS LIMITED

First Plaintiff

AFT ORPHAN PHARMACEUTICALS LIMITED
Second Plaintiff

AND

AFT PHARMACEUTICALS LIMITED

First Defendant

HARTLEY CAMPBELL ATKINSON

Second Defendant

Hearing: 17 April 2024

Appearances:

JS Cooper KC, TJ Lindsay and CD Brownlee for the Plaintiffs AS Ross KC and MC Smith for the Defendants

Judgment:

10 June 2024

Reissued:

20 June 2024


JUDGMENT OF FITZGERALD J

[As to form of account]


This judgment was delivered by me on 10 June 2024 at 4.00pm, pursuant to r 11.5 of the High Court Rules 2016. Registrar/Deputy Registrar  ………………….……………

Solicitors:           Lindsay & Francis, Auckland

Gilbert Walker, Auckland

To:J Cooper KC, Auckland A Ross KC, Auckland

PBL SOLUTIONS LTD v AFT PHARMACEUTICALS LTD [2024] NZHC 1511 [10 June 2024]

Introduction

[1]    In my judgment, delivered on 28 August 2023, I ordered that AFT Pharmaceuticals Ltd (AFT) give PBL Solutions Ltd (PBL) an account of profits arising from what is referred to as “the Pascomer opportunity” (in a 65 per cent/35 per cent proportionate share).1 I directed that the parties confer and seek to agree the form of the account.

[2]    The parties conferred and, while agreeing many aspects of the form of the account, they were unable to agree on some matters. This judgment accordingly determines the remaining matters in dispute. The lengthy and complex background to this dispute is set out fully in the introductory sections of my substantive judgment, and is not repeated here.

[3]    Before turning to the remaining disputes, I make one point by way of introduction. An account is effectively a process by which amounts that one party is required to account to another party for are identified and quantified. There is no doubt that it is a flexible remedy, and that r 16.3 of the High Court Rules 2016 reserves to the Court a broad power to make directions in relation to an account. It is nevertheless important, in my view, to consider the remaining matters in dispute through the lens of the Court making an order for an account, rather than, for example, fashioning other remedies or rights that did not form part of PBL’s original pleaded claims.

Should the account refer simply to “costs” or to “reasonable costs”?

[4]    In my substantive judgment, I determined that AFT’s costs of pursuing the Pascomer opportunity were to be an allowance in the account. There is a dispute as to whether the account should refer to this allowance as “the costs incurred by AFT or its Affiliates” (AFT’s position), or “the reasonable expenses incurred by AFT” (PBL’s position).


1      PBL Solutions Ltd v AFT Pharmaceuticals Ltd [2023] NZHC 2351 [substantive judgment]. The Pascomer opportunity is an opportunity to develop and sell an “orphan” drug called Pascomer. Orphan drugs are those which treat rare conditions. The Pascomer opportunity is currently being pursued by AFT.…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read PBL Solutions Limited v AFT Pharmaceuticals Limited and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2024] NZHC 1511
Decision Date

CaseChat Overview and Summary

In the case of PBL Solutions Limited v AFT Pharmaceuticals Limited, the High Court of New Zealand was tasked with determining the form of an account of profits arising from the "Pascomer opportunity." The dispute centered around several key issues: whether the account should refer to "costs" or "reasonable costs," whether PBL should have a veto right on the sale of the Pascomer opportunity by AFT, whether historical costs should exclude those exclusively attributable to the development of Pascomer for Port Wine Stain (PWS), whether a Crystaderm royalty should be allowed in the account of profits, and whether the account should include a written summary of any significant progress in the development or commercialisation of the Pascomer opportunity. The Court ruled that the account should refer simply to "costs" and not "reasonable costs," PBL should not have a veto right on the sale of the Pascomer opportunity, historical costs should exclude those exclusively attributable to the development of Pascomer for PWS, the Crystaderm royalty should be allowed in the account of profits, and the account should include a brief written summary of any significant progress in the development or commercialisation of the Pascomer opportunity. The Court also addressed ancillary matters regarding record keeping and audit rights, concluding that AFT's record retention obligation should be related to the content of the account and that PBL should have the right to audit the account but with certain limitations. The Court's final orders set out the form of the account of profits, including payment terms, reporting requirements, and audit provisions.

Orders

Orders of the court

Full text does not contain this section.

Background

Background to the litigation

Full text does not contain this section.

Evidence

Evidence Before The Court

Full text does not contain this section.

Decision

Reasons for decision

Full text does not contain this section.

Ratio Decidendi

Legal Principle Established

Full text does not contain this section.